These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22531078)

  • 1. Cosmetic safety: is there any?
    Simmons S
    Nursing; 2012 May; 42(5):54-5. PubMed ID: 22531078
    [No Abstract]   [Full Text] [Related]  

  • 2. Mirror, mirror on the wall, what's in my personal care products: a short article about 300 million "guinea pigs".
    Sattler B; Archer L; Houlihan J
    Oreg Nurse; 2006 Sep; 71(3):10. PubMed ID: 16989178
    [No Abstract]   [Full Text] [Related]  

  • 3. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB; Tressler L
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract]   [Full Text] [Related]  

  • 4. Not in my makeup: the need for enhanced premarket regulatory authority over cosmetics in light of increased usage of engineered nanoparticles.
    Johnson DR
    J Contemp Health Law Policy; 2009; 26(1):82-124. PubMed ID: 20112620
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 6. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety assessment of cosmetic ingredients present in technical information files of finished products.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():94-114. PubMed ID: 18806455
    [No Abstract]   [Full Text] [Related]  

  • 8. Annual Review of Cosmetic Ingredient Safety Assessments--2001/2002.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2003; 22 Suppl 1():1-35. PubMed ID: 12851163
    [No Abstract]   [Full Text] [Related]  

  • 9. Critical analysis of the safety assessment of cosmetic ingredients performed at the European level.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():58-93. PubMed ID: 18806454
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanotechnology in cosmetics.
    Katz LM; Dewan K; Bronaugh RL
    Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health effects of personal care products: a review of the evidence.
    Russ K
    Nurs Womens Health; 2009 Oct; 13(5):392-401. PubMed ID: 19821915
    [No Abstract]   [Full Text] [Related]  

  • 12. The cosmetic ingredient review self-regulatory safety program.
    Bergfeld WF; Elder RL; Schroeter AL
    Dermatol Clin; 1991 Jan; 9(1):105-22. PubMed ID: 2022088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges related to cosmetic safety assessment in the EU.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety Assessment of Dialkyl Sulfosuccinate Salts as Used in Cosmetics.
    Fiume MM; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):34S-46S. PubMed ID: 27913786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final report on the safety assessment of human placental protein, hydrolyzed human placental protein, human placental enzymes, human placental lipids, human umbilical extract, placental protein, hydrolyzed placental protein, placental enzymes, placental lipids, and umbilical extract.
    Nair B; Elmore AR;
    Int J Toxicol; 2002; 21 Suppl 1():81-91. PubMed ID: 12042062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tattoo ink-related infections--awareness, diagnosis, reporting, and prevention.
    LeBlanc PM; Hollinger KA; Klontz KC
    N Engl J Med; 2012 Sep; 367(11):985-7. PubMed ID: 22913662
    [No Abstract]   [Full Text] [Related]  

  • 17. The cosmetic ingredient review--a safety evaluation program.
    Elder RL
    J Am Acad Dermatol; 1984 Dec; 11(6):1168-74. PubMed ID: 6512061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globalization of cosmetic regulations.
    Blaschke JW
    Food Drug Law J; 2005; 60(3):413-9. PubMed ID: 16304748
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics.
    Becker LC; Boyer I; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):16S-33S. PubMed ID: 27913785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cosmetic industry. Year in review: 1995/1996.
    Barker MO
    Am J Contact Dermat; 1996 Dec; 7(4):251-3. PubMed ID: 8955490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.